MLLT3 and acute myeloid leukemia: Having observed that FADS1 expression was elevated in MLL-rearranged AML, we first performed loss-of-function analyses using shRNA-mediated knockdown in mouse models of AML, driven either by MLL-AF9 or MLL-eleven nineteen protein (ENL) (20, 21, 22).